English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review Journal article
Zhen Ruan, Yixuan Jiang, Honghao Shi, Ruxu Jia, Carolina Oi Lam Ung, Hao Hu. Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review[J]. Expert Review of Clinical Pharmacology, 2023, 16(2), 161-176.
Authors:  Zhen Ruan;  Yixuan Jiang;  Honghao Shi;  Ruxu Jia;  Carolina Oi Lam Ung; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:3.6/4.1 | Submit date：2023/08/03
Effectiveness  Glp-1ra  Hba1c  O.w. Semaglutide  Type 2 Diabetes  Real-world Evidence  Review  Weight  
Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China Journal article
Liu, Lei, Ruan, Zhen, Ung, Carolina Oi Lam, Zhang, Yawen, Shen, Yang, Han, Sheng, Jia, Ruxu, Qiao, Jingtao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China[J]. Diabetes Therapy, 2023, 14(1), 93-107.
Authors:  Liu, Lei;  Ruan, Zhen;  Ung, Carolina Oi Lam;  Zhang, Yawen;  Shen, Yang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:8  IF:2.8/2.9 | Submit date：2023/01/08
Cost-effectiveness Analysis  Type 2 Diabetes  Glucagon-like Peptide-1 Analogue  Semaglutide  Peg-loxenatide  China  
Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China Journal article
Ruan, Zhen, Ung, Carolina Oi Lam, Shen, Yang, Zhang, Yawen, Wang, Weihao, Luo, Jingyi, Zou, Huimin, Xue, Yan, Wang, Yao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China[J]. DIABETES THERAPY, 2022, 13(10), 1737-1753.
Authors:  Ruan, Zhen;  Ung, Carolina Oi Lam;  Shen, Yang;  Zhang, Yawen;  Wang, Weihao; et al.
Favorite | TC[WOS]:5 TC[Scopus]:8  IF:2.8/2.9 | Submit date：2022/08/28
China  Cost-effectiveness  Diabetes  Dulaglutide  Semaglutide  
The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review Review article
2021
Authors:  Zhen Ruan;  Lisong Yang;  Honghao Shi;  Xiaomeng Yue;  Yao Wang; et al.
Favorite | TC[WOS]:11 TC[Scopus]:13  IF:1.8/2.2 | Submit date：2021/03/01
Cost-effectiveness Analysis  Diabetes  Once-weekly Semaglutide  Review